Aurinia Pharmaceuticals Inc.

AUPH

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001600620

SEC filings (opens in a new tab)

In the last 90 days, Aurinia Pharmaceuticals Inc. insiders filed 0 open-market purchases and 2 sales; 282 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; no superinvestor holds it.

Superinvestors holding AUPH, Q2 2026

See all superinvestors

No superinvestor reported holding AUPH in Q2 2026.